Advertisement

Topics

Search Results for "Equine Leukemia Prognosis"

09:19 EST 18th January 2017 | BioPortfolio

Matching Channels

Acute Leukemia

Acute leukemia occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia...

Chronic Leukemia

Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...

Chronic Lymphocytic Leukemia CLL

Chronic lymphocytic leukemia is a disease in which mature lymphocytes become cancerous and gradually replace normal cells in lymph nodes. CLL mainly affects elderly males in North America and Europe...

Acute Myelocytic Leukemia AML

Acute myelocytic leukemia is a life-threatening disease in which the neutrophil, basophil, eosinophil, and monocyte precursors become cancerous and rapidly replace normal cells in the bone marrow. ...

Acute Lymphocytic Leukemia ALL

Acute lymphocytic leukemia (ALL) is a life-threatening disease in which the cells that normally develop into lymphocytes become cancerous and rapidly replace normal cells in the bone marrow. ALL acc...

Matching News

Genetic variant determines if stallions become carriers of equine arteritis virus

Following natural infection equine arteritis virus (EAV) establishes a long-term carrier state in the reproductive tract of stallions without any evidence of clinical signs. These carrier stallions ma...

Experimental Immune Cell Rx Shows Promise for Leukemia

WEDNESDAY, Sept. 21, 2016 -- An experimental therapy that revs up the immune system's cancer-fighting ability may help treat some leukemia patients who face a grim prognosis, a small study suggests. T...

Aggressive form of leukemia linked to defective 'protein factory'

(KU Leuven) 20 to 40 percent of the patients with multiple myeloma -- a type of leukemia -- have a defect in the ribosome, the protein factory of the cell. These patients have a poorer prognosis than ...

Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis

High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study

Global Equine Healthcare Market 20152019 Prices from USD $2500

About Equine HealthcareEquine health refers to veterinary services intended to treat horses to enhance their quality of life, increase their lifespan, and develop better quality animal food. Equine di...

Equine World Stem Cell Summit Partners With North American Veterinary Regenerative Medicine ...

WEST PALM BEACH, FL--(Marketwired - November 29, 2016) -Organizers of the Equine World Stem Cell Summit (EWSCS) are pleased to announce a partnership Read more...

Stem cell-based test predicts leukemia patients' response to therapy to help tailor treatment

Leukemia researchers have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.

Matching PubMed Articles

Risk factors in equine transport-related health problems: a survey of the Australian equine industry.

Transportation can affect equine health and is a potential source of economic loss to the industry.

CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia.

CD34 and CD38 proteins are usually used as surface markers to identify HSCs and Leukemic stem cells. However, there have been cases that lacked CD34 or CD38 protein but still had leukemia initiating c...

Science in brief: Highlights from the equine abstracts at the Eighth International Conference on Canine and Equine Locomotion.

Equine disease surveillance: quarterly summary.

Multiple reports of equine herpesvirus type 1 in the UKFirst cases of dourine in Botswana and equine infectious anaemia in GreeceSummary of UK surveillance testing, October to December 2015These are a...

Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.

Therapy-related acute myeloid leukemia (T-AML) is associated with poor prognosis after conventional therapy. Allogeneic hematopoietic cell transplantation (allo-HCT) has been proposed as a treatment f...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement